Colorado Therapeutics' Unattributed - II Round

Colorado Therapeutics raised a round of funding on April 17, 2017.

Colorado Therapeutics is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and va…

Articles about Colorado Therapeutics' Unattributed - II Round: